BACKGROUND: Cranial radiation therapy (RT) is an important component in the treatment of pediatric brain tumors. However, it can result in long-term effects on the developing brain. This prospective study assessed the effects of cranial RT on cerebral, frontal lobe, and temporal lobe volumes and their correlation with higher cognitive functioning. METHODS: Ten pediatric patients with primary brain tumors treated with cranial RT and 14 age-and sex-matched healthy children serving as controls were evaluated. Quantitative magnetic resonance imaging and neuropsychological assessments (language, memory, auditory and visual processing, and vocabulary) were performed at the baseline and 6, 15, and 27 months after RT. The effects of age, the time since RT, and the cerebral RT dose on brain volumes and neuropsychological performance were analyzed with linear mixed effects model analyses. RESULTS: Cerebral volume increased significantly with age in both groups (P 5.01); this increase in volume was more pronounced in younger children. Vocabulary performance was found to be significantly associated with a greater cerebral volume (P 5.05) and a lower RT dose (P 5.003). No relation was observed between the RT dose and the cerebral volume. There was no difference in the corresponding neuropsychological tests between the 2 groups. CONCLUSIONS: This prospective study found significant relations among the RT dose, cerebral volumes, and rate of vocabulary development among children receiving RT. The results of this study provide further support for clinical trials aimed at reducing cranial RT doses in the pediatric population. Cancer 2017;123:161-8.
INTRODUCTION
Primary brain tumors are the most common solid tumors in the pediatric population and account for approximately 20% of all childhood cancers. 1, 2 Cranial irradiation or craniospinal irradiation (CSI) is generally required after maximal surgical resection to achieve long-term disease control in children with posterior fossa tumors. Its use, however, is associated with cognitive impairments that can affect academic performance and future employment. 3, 4 Thus, as survival has improved for these children, the focus has shifted to concerns related to the long-term sequelae of treatment. Several studies have shown the contributions that the age at treatment and the cranial radiation therapy (RT) dose make to neuropsychological outcomes, and a reduction of the RT dose may limit the impact on intellectual functioning. 3, 4 The etiology of cognitive dysfunction is likely multifactorial. Research has shown that RT has been associated with a reduction in the volume of normal-appearing white matter (NAWM) in children with medulloblastoma. [5] [6] [7] [8] [9] This finding has also been shown to be dose-dependent, with reduced-dose CSI associated with a decreased rate of white matter loss in comparison with the standard dose. 7 Furthermore, this volume reduction has been reported to contribute to deficits in attention and lower measures of intelligence and academic achievement. 5, 6, 8 In this prospective study, our objective was to assess the effects of cranial RT on total cerebral, frontal, and temporal lobe volumes in pediatric patients with primary brain tumors. We hypothesized that these pediatric patients would have reduced cortical volumes in comparison with their age-and sex-matched healthy controls and also decreased performance on neuropsychological tests assessing region-specific higher cognitive functioning, including language, memory, processing speed, and vocabulary.
MATERIALS AND METHODS

Patients
Ten pediatric patients with primary brain tumors treated with cranial RT were evaluated. Fourteen age-and sexmatched healthy children composed the control group. It was planned for all patients to undergo a neuropsychological assessment at 4 time points: after surgery but before the start of RT (ie, the baseline) and 6, 15, and 27 months after RT. Corresponding time points were used for controls.
All participants were free of any psychiatric diagnosis according to the Diagnostic Interview for Children and Adolescents (4th edition) at the baseline and at each follow-up assessment. This prospective study was approved by the institutional review board of the Johns Hopkins Hospital, and informed consent was obtained from all families participating in the study.
Brain Region Contouring and Volume
High-resolution, T1-weighted images acquired on a 1.5-T magnetic resonance imaging (MRI) scanner using 1.5-mm slices were used. Cerebral, frontal lobe, and temporal lobe volumes were contoured with an online MRI crosssectional atlas of the brain serving as a reference (https:// www.imaios.com/en/e-Anatomy), and this was supervised by the pediatric neuroradiologist (D.L.) on the protocol. The volume of each brain region was computed with Pinnacle planning system software (Philips).
Neuropsychological Assessment
Neuropsychological tests were chosen on the basis of their established relation with the neurobehavioral functions and their association with specific brain regions under evaluation. Testing was completed under the supervision of a licensed psychologist in an outpatient setting and was administered by either a trained master's level psychology associate or a postdoctoral fellow. The neuropsychological assessment was performed at the baseline (after surgery but before the start of RT) and 6, 15, and 27 months after the completion of RT for patients and at the corresponding time points for controls. We focused on tests associated with higher cognitive functioning with established associations with regional cortical development in children, including vocabulary development (as a proxy for IQ), language, memory, and auditory/visual processing. Table 1 summarizes the neuropsychological tests and their relation to brain function and region.
Vocabulary (IQ estimate)
Peabody Picture Vocabulary Test 3 (PPVT-3) is a test of receptive single-word vocabulary and verbal ability. Participants are given a word and are asked to identify it among a group of 4 pictures. 10, 11 It is reported to correlate with the full-scale IQ of the Wechsler Intelligence Scale (3rd ed) at a rate of 0.90.
11
Language
Retrieval Fluency is a measure of verbal fluency that asks participants to name as many examples as possible from a given category and is a measure of rapid lexical retrieval and executive functioning. 10, 12 Declarative memory and working memory Memory for Words measures auditory verbal declarative memory. Participants are asked to repeat a list of unrelated words in the correct sequence. 10, 12 Auditory Working Memory asks participants to remember a combination of numbers and words and then reorder the numbers and words separately. It measures short-term auditory memory span and auditory working memory. 10, 12 Bead Memory is a measure of visual-spatial working memory and asks participants to reproduce the particular pattern of bead arrangement from memory on the basis of a picture of beads shown earlier. 10, 13 Auditory and visual processing Sound Blending is a measure of phonological awareness and auditory processing. In this test, participants are asked to synthesize phonologic components of words by listening to a series of sounds and then blend them into a word. 10, 12 Beery Visual Perception is a measure of motor-free visual perceptual skills and asks participants to match geometric forms from one shown.
10,14
Statistical Analysis
Linear mixed effects (LME) models were used to estimate changes in 1) brain volumes and 2) performance on associated neuropsychological tests between patients and Original Article controls (Group) and as a function of the age at the baseline (Age 0 ), the RT dose (Dose), and the time from the baseline (Visit). These analyses were conducted first with respect to cerebral volume and then for regional brain volumes (frontal and temporal lobes bilaterally). Additional interactions, Group 3 Visit and Group 3 Age 0 3 Visit, evaluating changes in brain volume with time between groups and changes in brain volume with age over time between groups, respectively, were included. LME analyses of changes in neuropsychological performance additionally included corresponding brain volumes (Table 1) as main effects. For those brain-behavior associations that showed a significant relation between brain volume and neuropsychological performance, a further LME analysis was conducted in patients to assess dose-dependent effects on neuropsychological performance; it used stratifications of the whole-brain dose (Dose Group: < 20, 20 to < 30, and 30 Gy) and included the Dose Group 3 Visit interaction. IBM SPSS Statistics 19 was used to calculate the LME regression analyses. A P value .05 was used to determine statistical significance.
RESULTS
Participants
All patients (n 5 10) presented with primary brain tumors at a median age at diagnosis of 9.0 years (range, 1.2-15.3 years). Patients were equally split between the sexes (5 males and 5 females), and the primary brain tumors consisted of medulloblastoma (n 5 6), ependymoma (n 5 3), and a malignant glioneuronal tumor (n 5 1). Patients with medulloblastoma were categorized as standard-or high-risk and received either 23.4 or 36 Gy of CSI, except for 1 patient who was treated with 28.8 Gy according to a Children's Oncology Group protocol. All medulloblastoma patients received chemotherapy as part of their initial treatment: concurrent vincristine followed by adjuvant vincristine, cyclophosphamide, and cisplatin per Children's Cancer Group (CCG) A9961 regimen B (n 5 2); concurrent vincristine followed by maintenance courses of a combination of vincristine, lomustine, and cisplatin as well as cyclophosphamide and vincristine per Children's Oncology Group study ACNS0331 (n 5 1); concurrent and adjuvant etoposide followed by a combination of cisplatin and etoposide as well as cyclophosphamide and vincristine per Pediatric Oncology Group 9631 (n 5 1); induction methotrexate, etoposide, cyclophosphamide, and cisplatin before RT followed by autologous stem cell transplantation after RT per CCG 99073 (n 5 1); and induction etoposide, cyclophosphamide, and cisplatin followed by autologous stem cell transplantation ahead of RT (n 5 1). Patients with ependymomas were treated with gross total resection followed by a definitive treatment to the tumor bed and, therefore, did not receive whole-brain RT and did not receive any chemotherapy. One patient, however, presented with a myxopapillary ependymoma of the lumbosacral spine and was later diagnosed with a grade 2 ependymoma of the left temporal lobe. This was resected and treated with adjuvant wholebrain RT followed by a tumor bed boost. One patient presented with a left frontal malignant glioneuronal tumor and was treated with gross total resection with recurrence 4 months later. He was treated with repeat resection followed by CSI with concurrent etoposide and adjuvant cyclophosphamide, cisplatin, and vincristine per CCG 99701. Table 2 summarizes the patient characteristics.
The baseline evaluation was undertaken at a median time of 62 days (range, 36-240 days) since surgery, and all patients either were free of neurological findings (n 5 5) or exhibited stable neurological symptoms (n 5 5): left upper extremity dysmetria and gait incoordination; mild ataxic gait; persistent/occasionally inappropriate laughter; left-sided facial hemiparesis and disconjugate gaze; and mild dysarthria (cerebellar mutism), dysmetria, and shuffling gait.
Eight patients completed the duration of the study; 2 patients passed away before the 15-and 27-month time points, respectively. Among the 8 patients completing the duration of the study, 5 completed the MRI evaluation at all 4 time points, and 3 completed the MRI evaluation at 3 time points. Three patients, 2 patients, and 2 patients completed neuropsychological testing at all 4 time points, at 3 time points, and at 2 time points, respectively, among the 8 patients completing the duration of the study. One patient (patient 5), enrolled at the age of 1.2 years, was able to successfully complete the MRI evaluation at all 4 time points; this patient underwent neuropsychological testing at only the final time point because of her age. The ages for control subjects ranged from 7.9 to 15.6 years. It was not possible to enroll controls less than 8 years old because they would have potentially required anesthesia for MRI; this was thought to be an unreasonable risk for the purpose of a clinical trial for the normal controls as dictated by our institutional review board. Figure 1 illustrates the different cerebral volumes of both patients and controls at each visit. Cerebral volume increased with age (interchild: P < .0001) and over time (intrachild: P 5 .012) in both patients and controls. Overall, cerebral volumes and the rate of growth of cerebral volumes, as determine by the slope, were higher in controls than patients, although the differences in slope were not statistically significant.
Change in Cerebral Volume
Cerebral Volume and Vocabulary Performance
Across groups and time points, a significant relation was observed between cerebral volume and performance on the test of vocabulary (PPVT-3; P 5 .05), with larger volumes associated with better performance (Fig. 2) , and there was no significant between the Group and Visit terms. Because cerebral volume increased with age and time in all children (both patients and controls), these results suggest that the reduced growth rate of cerebral volumes in patients was associated with slower vocabulary development.
Cerebral Radiation Dose and Vocabulary Performance
Across visits, a significant relation was observed between the cerebral RT dose and performance on the PPVT-3 (P 5 .003), with higher RT doses associated with lower scores in patients. This finding suggests that the RT dose affects performance on vocabulary measures in a dosedependent manner (Fig. 3 ). There were no significant interactions between the Dose Group and Visit terms.
Changes in Regional Volumes and Associated Neuropsychological Functions
Left and right temporal and frontal lobes were assessed individually. Similarly to the total cerebral volume (Fig. 1) , the bilateral frontal and left temporal lobe volumes increased with age in all children (P < .05). The right frontal lobe volumes (P < .05) and the right temporal lobe volumes (P < .05) differed significantly between patients and controls (controls > patients) across the 4 visits ( Figs. 4 and 5) . A follow-on assessment within these regions of brain-behavior relations (eg, right frontal lobe and visuospatial working memory) did not disclose any statistically significant associations.
DISCUSSION
The current treatment for pediatric patients with primary brain tumors generally involves maximal safe surgical resection followed by either CSI and/or tumor bed-directed RT. Cranial RT, however, is associated with a wide range of neurological sequelae in long-term survivors. The purpose of this prospective study was to assess the effects of cranial RT on cerebral, frontal lobe, and temporal lobe volumes and associations with higher cognitive functioning, including language, working memory, visual processing, and intelligence. Our results showed that cerebral volume increased with age and over time in both patients and controls, and this finding is consistent with current research on brain development. One large-scale longitudinal study on pediatric neuroimaging found a linear increase in white matter with age, but changes in cortical gray matter were regionspecific, with preadolescent peaks followed by a decline. 15, 16 The results described by Giedd et al 16 further showed increased total cerebral volume, which appeared to be due to significant increases in white matter volume that offset the relative decrease in gray matter volume.
We found a significant relation between cerebral volume and performance on the PPVT-3 (an IQ estimate), with larger volumes associated with higher scores. Although the treatment of primary brain tumors in children, and medulloblastoma in particular, is associated with neurocognitive deficits, the underlying pathophysiology is unknown. A multitude of research has shown an association between cranial RT and a reduction in the volume of NAWM; this suggests that reduced NAWM may be responsible in part for impairments in IQ. 12 One study comparing patients with medulloblastoma to agematched controls treated for low-grade astrocytomas of the posterior fossa with surgery alone found the former to have a significantly lower NAWM volume. 8 The importance of this study was that the 2 groups of patients were managed similarly with upfront surgical resection, with the main distinguishing treatment being whether or not they received CSI. The same study showed that the NAWM volume was significantly correlated with both verbal IQ and full-scale IQ in patients with medulloblastoma treated with CSI but failed to find any significant association between NAWM and any IQ score for the patients with low-grade astrocytomas. 8 The slowing of IQ growth over time among pediatric patients is not fully understood. One longitudinal study tested 2 competing hypotheses related to intellectual loss among survivors of pediatric medulloblastoma: whether it was related to a loss of previously learned information or an inability to acquire new information at a rate comparable to healthy subjects. 17 This study showed that the patients' IQ subtest raw scores increased significantly over time after CSI, but the rate of the increase was less than expected; this explained the overall decrease in IQ. 17 This was similar to our results, which showed that on average, the rate of growth of cerebral volume, as determined by the slope, was lower in patients than controls, although no significant difference in volume existed between the 2 groups. If we accept that an association exists between NAWM volume and intelligence, these results support the authors' conclusion that deficits in IQ are due to a diminished ability to acquire new information at a rate comparable to that of healthy controls. 17 It has been widely shown that reducing the cranial RT dose can limit the impact on intelligence. 5, 6 A longitudinal study evaluating brain volume changes over time in patients with medulloblastoma found that the rate of NAWM loss was 23% slower in children receiving reduced-dose CSI (23.4 Gy) versus conventional-dose CSI (36 Gy). 10 These results are similar to those of prior studies showing a relation between NAWM volume and IQ, and patients treated with CSI had a lower rate of growth of NAWM than controls; this explains their overall decrease in IQ. In our study, we stratified patients into 1 of 3 groups (<20 Gy, 20 to < 30 Gy, and 30 Gy) according to the dose of whole-brain RT received. The low-dose group was composed of patients with ependymoma who did not receive whole-brain radiation but instead received radiation to the posterior fossa tumor bed alone. The intermediatedose group was composed primarily of patients with standard-risk medulloblastoma, and the high-dose group was composed of patients with high-risk medulloblastoma. In comparison with previous investigations into NAWM and neurocognitive outcomes in this population, strengths of our investigation include its prospective basis and its control group of healthy subjects receiving no RT rather than patients receiving less RT.
Our results found a significant relation between the cerebral RT dose and performance on the PPVT, with higher doses associated with worse performance on this measure of intelligence. This relation was based on all patients over time, with no comparisons between groups at particular time points reaching statistical significance. This might be explained by the small patient numbers in each group and the resulting limited power for detecting differences between groups. Our findings are consistent with similarly published data. A study comparing patients with ependymoma to those with medulloblastoma found that patients with ependymoma, receiving posterior fossa RT only, were more likely to maintain an IQ greater than 90 than patients with medulloblastoma receiving CSI, with the latter having a progressive decline in IQ with time after CSI. 18 In another study that sought to analyze the relation between the CSI dose and the intellectual outcome for children with posterior fossa tumors, the authors also found a significant correlation between the full-scale IQ score and the CSI dose. 19 Similarly to our study, the patients were divided into 3 subgroups based on CSI doses (0, 25, and 35 Gy), with the low-dose (0 Gy) group comprising patients receiving posterior fossa-directed RT only.
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We also sought to evaluate other neuropsychological measures of higher cognitive functioning, including language, memory, and processing. We found that, similarly to the cerebral volume, the bilateral frontal and left temporal lobe volumes increased with age in all children. Interestingly, the right frontal and right temporal lobe volumes differed significantly between patients and controls, and this persisted over time, with controls having higher volumes than patients. However, the neuropsychological tests associated with these lobar regions, Bead Memory and Visual Perception, respectively, did not differ between patients and controls. This may be due to small patient numbers. It is possible that neuropsychological deficits other than intelligence may underlie the inability to acquire new information at a rate comparable to that of healthy controls. Reddick et al 15 sought to determine whether problems with memory and attention were responsible for the association between reduced volumes of NAWM and declines in IQ. Their study found that the main result of reduced NAWM among pediatric patients was decreased attention, not memory, and this is what led to declines in IQ and academic achievement. Although one limitation of our study was that we did not assess neuropsychological measures of attention, we similarly did not find a significant difference in memory between patients and controls; this may again be due to the small patient numbers.
The major limitation of this study is related to the small patient numbers. Ten patients with primary brain tumors were evaluated, and we further subdivided this already small group into 3 groups according to the CSI dose. For example, we identified that baseline measures of intelligence were different between patients stratified by the CSI dose even before radiation. Each individual group was thus likely more affected by outliers. Because our study was prospectively accrued and retrospectively evaluated, this limitation is one that is difficult to correct. A study by Mulhern et al 6 reporting on intellectual outcomes for childhood survivors of medulloblastoma found differences between groups with respect to the baseline full-scale IQ. In their discussion, the authors recommended stratifying patients on the basis of baseline neuropsychological performance before randomization as a way of reducing the initial differences between groups. This method would be an effective way to correct for the differences in baseline scores, although it will be even more important for larger patient numbers to be accrued because of the inherent differences in performance on such tests across the population. An additional factor to consider is that the design of the study limits interpretation to a certain extent because direct tumor effects and surgical interventions may also have made contributions to changes in neurocognitive function. It is possible that these factors may account for the differences at the baseline between patients and controls that were observed. The longitudinal design helps to alleviate these confounding factors, and our observation of dose-dependent effects suggests that radiation-related effects have been captured in this study. In the future, in addition to the enrollment of larger and more homogeneous populations, multiple control groups may be considered as well (eg, patients with low-grade gliomas treated with definitive surgery only and patients with untreated brain tumors). Longer term follow-up would also be useful for isolating the late effects of radiation from possible acute confounders. In a future study, one could also consider the enrollment of younger patients in particular because they are most likely to be affected by RT.
In conclusion, the cellular and molecular mechanism of cognitive dysfunction after cranial RT has yet to be fully understood. Current research has found an association between cranial RT and a reduction in NAWM, which suggests that this may be the underlying pathophysiology of intellectual impairment. The results of our prospective study show a significant relation with cerebral volume and RT dose for measures of intelligence. This study provides further support for clinical trials aimed at reducing the cranial RT dose in the pediatric population.
FUNDING SUPPORT
This work was supported by the National Institute of Neurological Disorders and Stroke of the National Institutes of Health (grant R01 NS04285).
CONFLICT OF INTEREST DISCLOSURES
Stephanie Terezakis reports grants and consultant fees from Elekta Industries outside the submitted work.
AUTHOR CONTRIBUTIONS
Harold Agbahiwe: Manuscript preparation, data interpretation, and data collection and analysis. Arif Rashid: Manuscript preparation and data interpretation. Alena Horska: Data collection and analysis, manuscript revision, and study conceptualization. E. Mark Mahone: Manuscript revision and study conceptualization. Doris Lin: Manuscript revision and study conceptualization. Todd McNutt: Manuscript revision and study conceptualization. Kenneth Cohen: Manuscript revision and study conceptualization. Kristin Redmond: Manuscript revision and study conceptualization. Moody Wharam: Manuscript revision and study conceptualization. Stephanie Terezakis: Manuscript preparation, data interpretation, manuscript revision, and study conceptualization.
